[{"Assets_0_Q1_USD":153314029.0,"CommonStockSharesOutstanding_0_Q1_shares":74627013.0,"EarningsPerShareBasic_1_Q1_USD":-0.31,"EarningsPerShareDiluted_1_Q1_USD":-0.31,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15227440.0,"NetIncomeLoss_1_Q1_USD":-23085907.0,"StockholdersEquity_0_Q1_USD":105849057.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":74300884.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":74152609.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170510"}]